Grassi, C <br/><br/>
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB).  [electronic resource] 

 -  Journal of chemotherapy (Florence, Italy)  Dec 2002 
 - 597-608 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1120-009X 
<br/><br/><label>Standard No.: </label>10.1179/joc.2002.14.6.597  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Anti-Infective Agents--administration & dosage<br/>Aza Compounds<br/>Bronchitis, Chronic--drug therapy<br/>Ceftriaxone--administration & dosage<br/>Costs and Cost Analysis<br/>Female<br/>Fluoroquinolones<br/>Humans<br/>Italy<br/>Male<br/>Middle Aged<br/>Moxifloxacin<br/>National Health Programs--economics<br/>Quinolines<br/>Time Factors<br/>Treatment Outcome